2BB score and signals
Celldex Therapeutics, Inc.’s current 2BB score is 17 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 28 | Weak |
| Quality | 100 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| Headquarters | Hampton, New Jersey, United States |
| Founded | 1983 |
| Employees | 198 |
| 52-week range | $19.72 – $39.16 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-23 | — | -1.0401 | — | $1.18M |
| 2026-11-09 | — | -1.0413 | — | $721,282.00 |
| 2026-08-06 | — | -1.0778 | — | $973,528.00 |
| 2026-05-06 | — | -1.1475 | — | $991,664.00 |
2BBBullish & Bearish